Both in Pharmaceuticals
Dare Bioscience vs Pasithea Therapeutics
Over the past year DARE returned −61.0% and KTTA returned −31.9%; their daily moves had a correlation of 0.07.
DARE −61.0% KTTA −31.9%Growth of $1, one year, split-adjusted
| Metric | DARE | KTTA |
|---|---|---|
| Price | $0.8150 | $0.4900 |
| Market cap | $16.0M | $16.4M |
| Today | +8.67% | +2.08% |
| 1 month | +10.9% | −12.5% |
| 6 months | −55.5% | −31.5% |
| Year to date | −57.8% | −62.0% |
| 1 year | −61.0% | −32.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | −70.6% | — |
| Net margin | −1590.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 11.7× | — |
| Net cash | $12.5M | $45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 128.9% | 63.3% |
| Short % of float | 5.0% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).